HeXun Biosciences Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 5, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,576	3,105	2,981	-	-
Market Cap Growth	-19.89%	4.17%	-	-	-
Enterprise Value	2,180	2,861	2,763	-	-
Last Close Price	56.00	67.50	64.80	-	-
PE Ratio	19.65	21.09	89.01	-	-
PS Ratio	8.46	10.84	22.83	-	-
PB Ratio	3.75	5.00	6.30	-	-
P/TBV Ratio	3.89	5.23	6.79	-	-
P/FCF Ratio	16.90	37.13	132.95	-	-
P/OCF Ratio	14.68	25.68	69.18	-	-
EV/Sales Ratio	7.16	9.99	21.16	-	-
EV/EBITDA Ratio	12.21	16.27	64.08	-	-
EV/EBIT Ratio	14.27	18.37	100.94	-	-
EV/FCF Ratio	14.30	34.21	123.24	-	-
Debt / Equity Ratio	0.05	0.06	0.15	0.23	0.35
Debt / EBITDA Ratio	0.19	0.20	1.56	13.75	-
Debt / FCF Ratio	0.22	0.42	3.24	7.16	-
Asset Turnover	0.44	0.45	0.27	0.14	-
Inventory Turnover	2.30	2.55	-	-	-
Quick Ratio	7.81	8.51	11.67	9.82	10.87
Current Ratio	8.26	8.99	12.05	10.55	11.94
Return on Equity (ROE)	21.24%	26.92%	8.50%	-1.96%	-
Return on Assets (ROA)	13.66%	15.23%	3.51%	-1.61%	-
Return on Capital (ROIC)	14.64%	16.20%	3.67%	-1.66%	-
Return on Capital Employed (ROCE)	21.30%	23.80%	5.10%	-2.30%	-17.70%
Earnings Yield	5.10%	4.74%	1.12%	-	-
FCF Yield	5.92%	2.69%	0.75%	-	-
Buyback Yield / Dilution	-0.01%	-1.61%	-20.81%	-22.92%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.